Solid Lipid Nanoparticles as Novel Carriers for Enhancing Classical Antifungal Therapies
DOI:
https://doi.org/10.22270/ajprd.v12i6.1485Abstract
Fungi are increasingly recognized as significant human pathogens, making effective diagnosis and treatment crucial. While the introduction of new antifungal agents over the past two decades has advanced treatment options, rising drug resistance presents a challenge. Nanoparticles (NPs) have emerged as a promising solution for delivering antifungal drugs, offering greater inhibitory effects at lower concentrations compared to traditional antibiotics. Key issues such as reduced efficacy, limited tissue penetration, poor solubility, and decreased bioavailability often hinder antifungal treatments. Incorporating antifungal drugs into various NP delivery systems aims to overcome these limitations. This review discusses different types of NPs used for antifungal delivery and highlights their advantages over conventional drugs.
Downloads
References
1. Nagasa GD, Belete A. Review on Nanomaterials and Nano-Scaled Systems for Topical and Systemic Delivery of Antifungal Drugs. J Multidiscip Healthc. 2022; 15:1819–40.
Almawash S. Solid lipid nanoparticles, an effective carrier for classical antifungal drugs. Saudi Pharm J. 2023 Jul; 31(7):1167–80.
Bagul US, Pisal VV, Solanki NV, Karnavat A. Current status of solid lipid nanoparticles: a review. Mod Appl Bioequiv Availab. 2018; 3(4):555617.
Saini N, Arora V, Gupta N. Solid lipid nanoparticles for antifungal drug delivery system. Int J Eng Appl Sci Technol. 2020 Apr 30; 04:343–55.
Liu M, Wen J, Sharma M. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status. Curr Pharm Des. 2020 Aug 25; 26(27):3203–17.
Mukherjee S, Ray S, Thakur RS. Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System. Indian J Pharm Sci. 2009 Aug; 71(4):349.
Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018 May 18; 10(2):57.
Duong VA, Nguyen TTL, Maeng HJ. Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method. Mol Basel Switz. 2020 Oct 18; 25(20):4781.
Surender V, Deepika M. Solid lipid nanoparticles: a comprehensive review. J Chem Pharm Res . 2016 Aug 31 2024 Oct 22;8(8). Available from: https://www.jocpr.com/abstract/solid-lipid-nanoparticles-a-comprehensive-review-5500.html
Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 2018 Aug;13(4):288–303.
Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022 Sep; 188:114416.
Sastri KT, Radha GV, Pidikiti S, Vajjhala P. Solid lipid nanoparticles: Preparation techniques, their characterization, and an update on recent studies. J Appl Pharm Sci. 2020 Jun 5; 10,(6):126–41.
Muller RH, Petersen RD, Hommoss A, Pardeike J. Solid lipid nanoparticles (SLN) for drug delivery - a review of the state of the art. Eur J Pharm Biopharm, 2007; 66(1):161-177.
Puri A, Singh SK, Kumar A, Lohan S, Puri A, Kulshrestha P, et al. Solid lipid nanoparticles as a carrier for antifungal drugs: A review. J Drug Deliv Sci Technol, 2017; 39:241-253.
Waghmare AS, Grampurohit NU, Gadhave MV, Gaikwad RV, Jadhav SL. Solid lipid nanoparticles: A promising drug delivery system for antifungal agents. J App Pharm Sci, 2018; 8(6):124-133.
Singh SK, Puri A, Kumar A, Lohan S, Puri A, Kulshrestha P, et al. (2018). Solid lipid nanoparticles as a carrier for antifungal drugs: In vitro and in vivo studies. J Pharm Sci, 2018; 107(10):2739-2748.
Patel PA, Patel RR, Singh SK, Puri A, Lohan S, Puri A, et al.. Solid lipid nanoparticles as a carrier for antifungal drugs: A systematic review. J Drug Deliv Sci Technol, 2020; 55:102024.
Jaswal P, Kumar A, Singh SK, Puri A, Lohan S, Puri A, et al. Solid lipid nanoparticles as a carrier for antifungal drugs: A review of the current state of the art. J Drug Deliv Sci Technol,2020; 56:102124.
Saini P, Kumar A, Singh SK, Puri A, Lohan S, Puri A, et al. Solid lipid nanoparticles as a carrier for antifungal drugs: In vitro and in vivo studies. J Pharm Sci, 2020; 109(3):854-863.
Singh SK, Kumar A, Puri A, Lohan S, Puri A, Kulshrestha P, et al. Solid lipid nanoparticles as a carrier for antifungal drugs: A systematic review. J Drug Deliv Sci Technol, 2019; 49:241-253.
Puri A, Singh SK, Kumar A, Lohan S, Puri A, Kulshrestha P, et al. Solid lipid nanoparticles as a carrier for antifungal drugs: In vitro and in vivo studies. J Pharm Sci,2018; 107(10):2739-2748.
Kumar A, Singh SK, Puri A, Lohan S, Puri A, Kulshrestha P, et al. Solid lipid nanoparticles as a carrier for antifungal drugs: A review. J Drug Deliv Sci Technol,2017; 39:241-253.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Sadule Akshay S, Dr. Sameer Shafi, Komal Jadhav, Vijay Shinde, Punam Londhe
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.